Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.28
-0.01 (-0.08%)
At close: Aug 14, 2026, 4:00 PM EDT
13.27
-0.01 (-0.08%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Korro Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 |
| - | - | 1.29 | 1.09 | 1.46 | 2.55 | 2.27 | - | - | - | - | - | - | - | - | - | - | - | |
Revenue Growth (YoY) | - | - | -43.11% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 11.63 | 11.53 | 8.6 | 11.26 | 17.46 | 18.49 | 14.18 | 13.09 | 14.28 | 10.76 | 48 | - | - | - | - | - | - | - |
Gross Profit | -11.63 | -11.53 | -7.31 | -10.17 | -16 | -15.94 | -11.91 | -13.09 | -14.28 | -10.76 | -48 | - | - | - | - | - | - | - |
Selling, General & Admin | 8.48 | 8.91 | 8.58 | 9.06 | 9.97 | 9.08 | 11.13 | 10.2 | 9.84 | 10.69 | 14.35 | 7.79 | 7.54 | 5.89 | 5.63 | 6.72 | 4.98 | 4.06 |
Research & Development | - | - | - | - | - | - | - | - | - | - | -35.45 | 11.36 | 10.87 | 14.2 | 10.83 | 9.01 | 8.19 | 9.58 |
Operating Expenses | 8.48 | 8.91 | 8.58 | 9.06 | 9.97 | 9.08 | 11.13 | 10.2 | 9.84 | 10.69 | -21.11 | 19.15 | 18.41 | 20.09 | 16.46 | 15.73 | 13.17 | 13.64 |
Operating Income | -20.11 | -20.44 | -15.88 | -19.24 | -25.97 | -25.02 | -23.04 | -23.29 | -24.13 | -21.45 | -26.89 | -19.15 | -18.41 | -20.09 | -16.46 | -15.73 | -13.17 | -13.64 |
Interest & Investment Income | 1.3 | 0.91 | - | - | 1.43 | 1.63 | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income (Expenses) | - | - | 0.99 | 1.18 | - | - | 1.94 | 2.28 | 2.33 | 1.91 | 1.47 | 0.66 | 0.79 | 0.48 | 0.44 | 0.36 | 0.13 | 0.06 |
EBT Excluding Unusual Items | -18.81 | -19.53 | -14.89 | -18.06 | -24.54 | -23.39 | -21.1 | -21.01 | -21.8 | -19.54 | -25.43 | -18.49 | -17.62 | -19.61 | -16.02 | -15.38 | -13.04 | -13.58 |
Merger & Restructuring Charges | - | - | -3.63 | - | -1.23 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Asset Writedown | - | - | -30.89 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -18.81 | -19.53 | -49.41 | -18.06 | -25.77 | -23.39 | -21.1 | -21.01 | -21.8 | -19.54 | -25.43 | -18.49 | -17.62 | -19.61 | -16.02 | -15.38 | -13.04 | -13.58 |
Income Tax Expense | 0.11 | 0.1 | 0.64 | - | 0 | - | 0.1 | -0.01 | 0.03 | 0.02 | - | - | 0.03 | - | 0.01 | - | - | - |
Net Income | -18.92 | -19.63 | -50.04 | -18.06 | -25.77 | -23.39 | -21.2 | -21 | -21.83 | -19.56 | -25.43 | -18.49 | -17.65 | -19.61 | -16.03 | -15.38 | -13.04 | -13.58 |
Net Income to Common | -18.92 | -19.63 | -50.04 | -18.06 | -25.77 | -23.39 | -21.2 | -21 | -21.83 | -19.56 | -25.43 | -18.49 | -17.65 | -19.61 | -16.03 | -15.38 | -13.04 | -13.58 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 18 | 12 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 5 | 0 | 0 | 0 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 18 | 12 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 5 | 0 | 0 | 0 | 5 | 5 | 5 | 5 |
Shares Change (YoY) | 87.62% | 23.60% | 0.51% | 0.95% | 4.50% | 17.02% | 77.24% | 3173.98% | 3150.32% | 2853.58% | -2.20% | -94.56% | -94.55% | -94.43% | - | - | - | - |
EPS (Basic) | -1.07 | -1.69 | -5.32 | -1.92 | -2.74 | -2.49 | -2.26 | -2.26 | -2.43 | -2.44 | -4.81 | -65.08 | -63.83 | -72.20 | -2.97 | -2.94 | -2.57 | -2.78 |
EPS (Diluted) | -1.07 | -1.69 | -5.32 | -1.92 | -2.74 | -2.49 | -2.26 | -2.26 | -2.43 | -2.44 | -4.81 | -65.08 | -63.83 | -72.20 | -2.97 | -2.94 | -2.57 | -2.78 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow | -17.03 | -16.1 | -17.79 | -17.35 | -19.37 | -24.57 | -8.95 | -20.97 | -20.55 | -27.5 | -22.76 | -12.02 | -19.14 | -21.2 | -16.44 | -15.93 | -12.47 | -14.02 |
Free Cash Flow Per Share | -0.97 | -1.39 | -1.89 | -1.85 | -2.06 | -2.62 | -0.95 | -2.25 | -2.29 | -3.43 | -4.31 | -42.29 | -69.22 | -78.09 | -3.04 | -3.05 | -2.46 | -2.87 |
Operating Margin | - | - | -1229.33% | -1764.86% | -1778.70% | -981.18% | -1014.53% | - | - | - | - | - | - | - | - | - | - | - |
Profit Margin | - | - | -3873.22% | -1656.97% | -1765.07% | -917.14% | -933.47% | - | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | -1376.63% | -1592.11% | -1326.58% | -963.57% | -393.97% | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | -19.75 | -20.06 | -15.23 | -18.06 | -24.74 | -23.8 | -21.79 | -22.43 | -23.4 | -20.73 | -25.91 | -18.23 | -17.49 | -19.28 | -15.71 | -15.05 | -12.61 | -13.12 |
D&A For EBITDA | 0.37 | 0.38 | 0.65 | 1.18 | 1.23 | 1.23 | 1.25 | 0.87 | 0.72 | 0.73 | 0.99 | 0.92 | 0.92 | 0.81 | 0.75 | 0.69 | 0.56 | 0.51 |
EBIT | -20.11 | -20.44 | -15.88 | -19.24 | -25.97 | -25.02 | -23.04 | -23.29 | -24.13 | -21.45 | -26.89 | -19.15 | -18.41 | -20.09 | -16.46 | -15.73 | -13.17 | -13.64 |